Arcellx (ACLX) Total Non-Current Liabilities (2021 - 2025)

Arcellx (ACLX) recorded quarterly Total Non-Current Liabilities of $201.6 million in Q4 2025, down 6.28% quarter-over-quarter from $215.1 million in Q3 2025, and down 18.67% on a YoY basis from $247.9 million in Q4 2024.

Arcellx (ACLX) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

Arcellx's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $201.6 million for Q4 2025.

  • In Q4 2025, Total Non-Current Liabilities fell 18.67% year-over-year to $201.6 million; the TTM figure through Dec 2025 stood at $201.6 million (down 18.67% YoY), while the FY2025 annual figure was $201.6 million, down 18.67% from the prior year.
  • Total Non-Current Liabilities was $201.6 million for Q4 2025 at Arcellx, down from $215.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $267.7 million in Q1 2024 to a low of $16.7 million in Q4 2021.
  • Historically, Total Non-Current Liabilities has averaged $179.3 million across 4 years, with a median of $226.9 million in 2025.
  • Biggest YoY gain for Total Non-Current Liabilities was 2.32% in 2025; the steepest drop was 19.38% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $16.7 million in 2021, then surged by 204.22% to $50.9 million in 2022, then soared by 386.86% to $247.9 million in 2024, then declined by 18.67% to $201.6 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $201.6 million (Q4 2025), $215.1 million (Q3 2025), and $226.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 201.64 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 201.64 Mn
Sep 30, 2025 215.14 Mn
Jun 30, 2025 226.86 Mn
Mar 31, 2025 227.74 Mn
Dec 31, 2024 247.94 Mn
Sep 30, 2024 266.84 Mn
Jun 30, 2024 232.24 Mn
Mar 31, 2024 267.65 Mn
Jun 30, 2022 50.93 Mn
Mar 31, 2022 18.90 Mn
Dec 31, 2021 16.74 Mn